Search

everythinglearnresearchcommunity

for

Search:↓

Modified laparoscopic sleeve gastrectomy effectively controls diabetes and treats obesity with minimal complications.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Shi-Bi-Man, a Traditional Chinese Medicine, helps grow hair by boosting lactic acid metabolism and activating hair follicle stem cells.

The review concludes that pharmacists should clearly define their product as more than medication, including their knowledge and services, to effectively communicate their value.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Herbal remedies can cause adverse effects and need more safety research.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 may cause hair loss due to infection stress or treatments.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Testosterone may influence COVID-19 severity and outcomes.

Men with severe balding have a higher risk of getting very sick from COVID-19.